Observational study shows high-dose corticosteroids increase complications in myasthenia gravis patients, suggesting a need for careful management.
Use of high-dose OCS in patients with MG was associated with adverse outcomes, including increased rates of long-term hospitalizations and clinical complications.
No takes yet. Share an insight, caveat, or question.
Numajiri et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: